New Alzheimer’s drug data highlights increased
Browsing: All news
Category Added in a WPeMatico Campaign
Study identifies the nuclear protein Pin1 as piv
Seed round led by SV Health and Two Bear Capital
Study shows Shingrix vaccine may delay dementia
Cognition Therapeutics reports once-daily drug’s potential to slow Alzheimer’s progression, showing promise with favorable safety profile. Cognition Therapeutics, Inc. recently disclosed findings from their Phase 2 SHINE trial, investigating the efficacy of CT1812, an experimental oral treatment for Alzheimer’s disease.…
Recent study indicates that hyperbaric oxygen th
New research highlights inconsistency in lifespa
Crossbench peer urges UK Parliament to consider
Season finale to The Kardashians sees the family
Citing rise in GLP-1 popularity, longevity biote